Dizal Pharmaceutical Co (SHSE:688192) Inventories, Work In Process: ¥0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688192 Dizal Pharmaceutical Co Ltd SHSE:688192
27 GF Score
Price ¥46.66
GF Value ¥135.86
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Dizal Pharmaceutical Co Inventories, Work In Process?

Dizal Pharmaceutical Co SHSE:688192 -0.60% 27 Inventories, Work In Process is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SHSE:688192 with a GF Score™ of 27/100 and a GF Value™ of ¥135.86 (Possible Value Trap). The stock has 4 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Dizal Pharmaceutical Co's work in process for the quarter that ended in Mar. 2026 was ¥0.0 Mil.

Dizal Pharmaceutical Co Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Dizal Pharmaceutical Co's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dizal Pharmaceutical Co Inventories, Work In Process Chart

Dizal Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Dizal Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:688192
27GF Score
Dizal Pharmaceutical Co Ltd SHSE:688192
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dizal Pharmaceutical Co Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ¥0.0 Mil mean?
Dizal Pharmaceutical Co (SHSE:688192) has a Inventories, Work In Process of ¥0.0 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Dizal Pharmaceutical Co and its competitors.
Is Dizal Pharmaceutical Co's Inventories, Work In Process too high?
Dizal Pharmaceutical Co's current Inventories, Work In Process is ¥0.0 Mil. Overall, Dizal Pharmaceutical Co has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dizal Pharmaceutical Co's Inventories, Work In Process compare to ZTS and UTHR?
Dizal Pharmaceutical Co's Inventories, Work In Process of ¥0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Dizal Pharmaceutical Co and its competitors. Dizal Pharmaceutical Co's current Inventories, Work In Process is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dizal Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Dizal Pharmaceutical Co (SHSE:688192) is currently considered Possible Value Trap. The stock's GF Value™ is ¥135.86, compared to a current price of ¥46.66 — trading 65.7% below its estimated fair value. The current Inventories, Work In Process is ¥0.0 Mil. Dizal Pharmaceutical Co's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Dizal Pharmaceutical Co (SHSE:688192), the current Inventories, Work In Process is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dizal Pharmaceutical Co (SHSE:688192) Overvalued in 2026?

Based on GuruFocus' analysis, Dizal Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥46.66 is trading 65.7% below its estimated GF Value™ of ¥135.86. GuruFocus considers Dizal Pharmaceutical Co to be Possible Value Trap.

Key valuation signals for SHSE:688192:

  • Inventories, Work In Process: ¥0.0 Mil
  • GF Value™: ¥135.86 vs. price of ¥46.66 (65.7% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dizal Pharmaceutical Co Business Description

Address Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203
Dizal Pharmaceutical Co Ltd, formerly Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
27GF Score

Get the complete analysis for SHSE:688192

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥46.66
Price
¥135.86
GF Value